By Jason Napodano, CFA
This morning, Cipher Pharmaceuticals (DND.TO) (OTC:CPHMF) posted an updated investor presentation on its website. It shows that business is chugging along nicely at Cipher. Back in May 2013, we announced that we were raising our earnings forecasts for the company, yet again, after a solid first quarter 2013 report. In the first quarter 2013, Cipher delivered $3.3 million in revenues and $1.5 million in net income (+6 cents per share). Revenues increased by 82% over the first quarter 2012. It was the fifth quarter in a row of greater than 80% year-over-year revenue growth and the fifth quarter in a row of positive earnings per share.
The new investor presentation highlights many of...
Only subscribers can access this article, which is part of the PRO research library covering 3,594 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: